Theravance Biopharma, Inc. (TBPH)
$17.04+$0.01 (+0.06%) Today
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 356,975 | $6.13M |
| Grant or award | 11 | 115,785 | |
| Tax withholding / forfeiture | 5 | 48,023 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
56 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Eran Broshy | Open-market sale | Ordinary Shares | 14,000 | $20.00 | $280K | |
| Eran Broshy | Open-market sale | Ordinary Shares | 15,501 | $20.00 | $310K | |
| Eran Broshy | Option exercise | Share Option (Right to Buy) | 14,000 | $10.15 | $142K | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 18,627 | $17.90 | $333K | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,989 | $17.90 | $125K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,060 | $17.90 | $162K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 19,024 | $17.90 | $341K | |
| Rick E. Winningham - Officer | Gift | Ordinary Shares | 9,900 | $0.00 | - | |
| Rick E. Winningham - Officer | Gift | Ordinary Shares | 9,900 | $0.00 | - | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 56,817 | $17.90 | $1.02M | |
| Eran Broshy | Open-market sale | Ordinary Shares | 29,500 | $18.50 | $546K | |
| Eran Broshy | Open-market sale | Ordinary Shares | 15,500 | $17.00 | $264K | |
| Eran Broshy | Open-market sale | Ordinary Shares | 14,000 | $18.50 | $259K | |
| Eran Broshy | Option exercise | Share Option (Right to Buy) | 14,000 | $10.15 | $142K | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,989 | $13.39 | $94K | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,368 | $13.39 | $125K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,762 | $13.39 | $131K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,096 | $13.39 | $122K | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 15,394 | $13.39 | $206K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 682 | $11.39 | $8K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 5,318 | $11.39 | $61K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 4,000 | $11.39 | $46K | |
| Rick E. Winningham - Officer | Gift | Ordinary Shares | 20,000 | $0.00 | - | |
| Rick E. Winningham - Officer | Gift | Ordinary Shares | 9,600 | $0.00 | - | |
| Rick E. Winningham - Officer | Gift | Ordinary Shares | 9,600 | $0.00 | - | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 15,364 | $9.45 | $145K | |
| Dean J. Mitchell | Grant or award | Ordinary Shares | 10,649 | $0.00 | - | |
| Dean J. Mitchell | Grant or award | Share Option (Right to Buy) | 24,258 | $0.00 | - | |
| Deepika Pakianathan | Grant or award | Ordinary Shares | 10,649 | $0.00 | - | |
| Deepika Pakianathan | Grant or award | Share Option (Right to Buy) | 24,258 | $0.00 | - | |
| Eran Broshy | Grant or award | Ordinary Shares | 10,649 | $0.00 | - | |
| Eran Broshy | Grant or award | Share Option (Right to Buy) | 24,258 | $0.00 | - | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 10,076 | $9.97 | $100K | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 15,997 | $9.97 | $159K | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 8,477 | $9.97 | $85K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,268 | $9.97 | $92K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 9,178 | $9.97 | $92K | |
| Rick E. Winningham - Officer | Grant or award | Ordinary Shares | 3,193 | $9.57 | $31K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 4,000 | $9.00 | $36K |
This is as far as the anonymous view goes. Create a free account for all 56 TBPH filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Theravance Biopharma, Inc. (TBPH) had 14 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for TBPH runs to 56 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TBPH were filed in the last 90 days.
8 insider sales of TBPH were filed in the last 90 days, totaling $6.13M.
This page tracks TBPH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TBPH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
